J Biol Chem, Vol. 274, Issue 43, 30424-30432, October 22, 1999
Post-transcriptional Regulation of the Arginine Transporter
Cat-1 by Amino Acid Availability*
Kulwant S.
Aulak
,
Rangnath
Mishra
,
Lingyin
Zhou
,
Susannah
L.
Hyatt
,
Wouter
de Jonge§,
Wouter
Lamers§,
Martin
Snider¶, and
Maria
Hatzoglou
From the
Department of Nutrition and
¶ Department of Biochemistry, Case Western Reserve University
School of Medicine, Cleveland, Ohio 44106 and the
§ Laboratory of Anatomy and Embryology, University of
Amsterdam, Amsterdam, The Netherlands
 |
ABSTRACT |
The regulation of the high affinity cationic
amino acid transporter (Cat-1) by amino acid availability has been
studied. In C6 glioma and NRK kidney cells, cat-1 mRNA
levels increased 3.8-18-fold following 2 h of amino acid
starvation. The transcription rate of the cat-1 gene
remained unchanged during amino acid starvation, suggesting a
post-transcriptional mechanism of regulation. This mechanism was
investigated by expressing a cat-1 mRNA from a
tetracycline-regulated promoter. The cat-1 mRNA
contained 1.9 kilobase pairs (kb) of coding sequence, 4.5 kb of
3'-untranslated region, and 80 base pairs of 5'-untranslated region.
The full-length (7.9 kb) mRNA increased 5-fold in amino
acid-depleted cells. However, a 3.4-kb species that results from the
usage of an alternative polyadenylation site was not induced,
suggesting that the cat-1 mRNA was stabilized by
cis-acting RNA sequences within the 3'-UTR. Transcription
and protein synthesis were required for the increase in full-length cat-1 mRNA level. Because omission of amino acids from
the cell culture medium leads to a substantial decrease in protein
synthesis, the translation of the increased cat-1 mRNA
was assessed in amino acid-depleted cells. Western blot analysis
demonstrated that cat-1 mRNA and protein levels changed
in parallel. The increase in protein level was significantly lower than
the increase in mRNA level, supporting the conclusion that
cat-1 mRNA is inefficiently translated when the supply
of amino acids is limited, relative to amino acid-fed cells. Finally,
y+-mediated transport of arginine in amino acid-fed and
-starved cells paralleled Cat-1 protein levels. We conclude that the
cat-1 gene is subject to adaptive regulation by amino acid
availability. Amino acid depletion initiates molecular events that lead
to increased cat-1 mRNA stability. This causes an
increase in Cat-1 protein, and y+ transport once amino
acids become available.
 |
INTRODUCTION |
The study of the mechanisms involved in the response of mammalian
cells to amino acid availability lags behind the studies in bacteria
and yeast cells. In mammalian cells, decreased amino acid availability
causes substantially decreased protein synthesis (1), as well as
changes in mRNA stability and gene transcription (2). Inhibition of
protein synthesis involves phosphorylation of the translation factor
eIF-2 (3). This results in the sequestration of eIF-2B, with a decrease
in the availability of eIF2·GTP·Met-tRNA ternary complexes for
binding to the 40 S ribosomal subunits (4). Saccharomyces
cerevisiae yeast cells have the ability to compensate for the
effects of total or individual amino acid starvation by activating the
transcription of the genes involved in amino acid biosynthesis, through
a general control mechanism (5). The mechanism involves the enhancement
of translation of the transcription factor GCN4 (6, 7), which in turn
induces transcription of the amino acid biosynthetic genes (8). It has
been suggested that mammalian cells, like yeast, have a general control
mechanism to respond to amino acid limitations for genes involved in
different aspects of amino acid metabolism (5). Specific examples of mRNAs or proteins for which synthesis is enhanced in response to
amino acid deprivation include serine dehydratase (9), asparagine synthase (10), ornithine decarboxylase (11, 12), and the glutamate
transporter EAAC1 (13). However, the molecular mechanism of regulation
of gene expression by amino acid availability has only been studied for
the asparagine synthase (AS)1
gene (9, 14, 15). The steady state level of AS mRNA has been shown
to be increased by amino acid starvation (15). This increase is caused
both by an increase in gene transcription (15) and an increase in
mRNA stability (10).
Changes in mRNA stability influence gene expression in mammalian
cells (16). The steady state level of an mRNA is a reflection both
of its rate of synthesis and its rate of degradation. Amino acid
depletion has been shown to increase the stability of the AS mRNA
(10). We have previously shown that expression of the cationic amino
acid transporter gene, cat-1, is subject to adaptive regulation by amino acid availability in cultured hepatoma cells by a
post-transcriptional mechanism of regulation (17). The cat-1
mRNA level increased in cells depleted of amino acids and returned
to fed levels when starved cells were shifted to amino acid-containing
medium (17). Although protein synthesis is decreased during amino acid
depletion, some mRNAs are preferentially translated (1). Therefore,
increased cat-1 mRNA levels could result in sustained or
increased protein levels in depleted cells. Moreover, the increased
cat-1 mRNA will be available for protein synthesis once
amino acid levels return to normal.
In this paper we investigate the mechanism by which amino acid
starvation causes an accumulation of cat-1 mRNA. First,
we show that amino acid depletion causes accumulation of
cat-1 mRNA in cultured C6 glioma and NRK kidney cells in
addition to the hepatoma cells we studied previously (17). Second, we
show that the mechanism of mRNA accumulation does not involve
regulation of transcription. Rather, increased mRNA half-life in
amino acid-starved cells is responsible for the accumulation. This
stabilization appears to be caused by the interaction of
trans-acting factors with sequences in the 3'-UTR of the
cat-1 mRNA in amino acid-depleted cells. Finally, we
show that increased cat-1 mRNA stability results in
increased Cat-1 protein and increased cationic amino acid transport.
The transport of cationic amino acids into most mammalian cells is
mediated mainly by system y+ (18). Four related proteins
have been identified that differ in their affinity for substrate
(19-21). The genes of these proteins are expressed in a
tissue-specific manner, thus regulating amino acid flux for
tissue-specific nutritional needs (19). The cat-1 transporter is the only member of the y+ transporter family
that has been reported to be regulated by amino acid availability
(17).
 |
EXPERIMENTAL PROCEDURES |
Materials--
All DNA modifying enzymes and nucleotides were
purchased from Roche Molecular Biochemicals.
[
-32P]dCTP (3000 Ci/mmol) was purchased from NEN Life
Science Products. Dialyzed bovine serum (dFBS) was purchased from Life
Technologies, Inc. L-[2,3,4,5-3H]Arginine
monohydrochloride (63 Ci/mmol) was purchased from Amersham Pharmacia
Biotech. All other chemicals and media were from Sigma.
Tissue Culture Cells--
C6 and NRK cells were maintained in
10% FBS-supplemented DMEM/F-12 medium. Amino acid-fed cells were
cultured in dFBS-supplemented DMEM/F-12 (fed), whereas cells were amino
acid-depleted by culture in dFBS-supplemented Krebs-Ringer bicarbonate
(KRB) buffer (starved).
Generation of the WCAT-1 Antibody--
Polyclonal antiserum was
raised against an oligopeptide (LAAGQAKTPDSNLDQ), corresponding to
predicted amino acids 605-620 of the murine cat-1 cDNA
(22). The peptide has 100% homology with the equivalent sequence of
the rat protein. A cysteine was added to the N terminus of the
oligopeptide to allow coupling to keyhole limpet hemocyanin. The
complex contained 0.7 mg of peptide/mg of keyhole limpet hemocyanin.
The complex (1.7 mg of protein/ml) was diluted 1:1 with Freund's
adjuvant, and 118 µl of the mixture was injected intradermally into
rabbits. Rabbits were boosted five times, and were bled 120 days after
the first immunization.
Plasmids and Transfection of Cells--
The following plasmids
were used to generate the ptetcat-1 and ptetR5 expression
vectors: (i) pUHD10-3 containing the hCMV minimal promoter (23) with
the heptamerized tet operator (23), (ii) pUHD172-1neo,
containing the rtTA gene and the neo marker gene
(23), and (iii) pMP10 (24) containing a 6.5-kb cat-1 cDNA (Fig. 1). The full-length cat-1 cDNA is 6.573 bp (24),2 suggesting an
approximate 7.0-kb cat-1 mRNA. However, in the present
study, the size of the cat-1 mRNA is described as 7.9 kb, to be consistent with earlier reports that estimated the size based
on the electrophoretic mobility of the cat-1 mRNA on
agarose gels (22). To generate the ptetcat-1 expression
vector, the XhoI/SmaI fragment containing the
entire cat-1 cDNA (25) was isolated from pMP10 and
ligated into the BamHI site of the pUHD10-3 plasmid by
blunt-end ligation (Fig. 1). The ptetR5 expression vector was generated
by cloning a 1.1-kb EcoRI fragment of the 5'-end of the
cat-1 cDNA (25) into the EcoRI site of
pUHD10-3 (Fig. 1). pUHD172-1neo DNA was
cotransfected with either ptetcat-1 or ptetR5 into C6 cells
using the calcium phosphate precipitation method (26). Transfected
cells were selected in G418 (0.1%), and individual clones were
screened for responsiveness to Dox (5 µg/ml for 36 h). The
clones C6/7-3, C6/7-5, and C6/R5 were used in this study.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
DNAs used in the study of the
post-transcriptional regulation of the cat-1 gene by
amino acid depletion. The full-length cat-1 cDNA is
6.6 kb and consists of 200 bp of 5'-UTR, 1.9 kb of coding region
(shaded black), and 4.5 kb of 3'-UTR. The polyadenylation
signals that generate the cat-1//7.9 and
cat-1/3.4-kb mRNAs are marked. The previously described
(25) cat-1/6.5 cDNA is lacking 120 bp from the 5'-UTR.
The tetcat-1 cDNA was generated by ligating the
cat-1/6.5 cDNA to the tet promoter, 80 bp
downstream of the transcription start site. The tetR5 vector
was generated by ligating 1020 bp from the 5'-end of the
cat-1/6.5 to the tet promoter as described for
the tetcat-1. The 5'-cat-1 and tet
probes that were used for Northern blot analysis are indicated
(shaded gray).
|
|
DNA Hybridization Probes--
The following DNAs were used to
generate the probes employed in this study: (i) cat-1, a
6.5-kb fragment of the rat cat-1 cDNA (25); (ii)
5'-cat-1, a 0.1-kb fragment within the 5'-UTR of the
cat-1 cDNA2; (iii) GAPDH, a 1.4-kb
glyceraldehyde-3-phosphate dehydrogenase cDNA (25); (iv) AS, a
0.9-kb fragment of the rat AS cDNA (14); (v) c-fos, a
1.0-kb fragment of the c-fos cDNA (25); (vi)
c-jun, a human c-JUN cDNA (25); (vii)
tet, a 0.157-kb KpnI fragment from the
tet promoter (23); (viii) c-myc, a 4.8-kb genomic
fragment of the mouse c-myc oncogene (27); (ix) 18 S, a
5.8-kb fragment containing the 18 S mouse ribosomal DNA (28). Probes
for Northern blot analysis were generated by random primed labeling
with [
-32P]dCTP in the reaction mix using a kit from
Roche Molecular Biochemicals. The specific activity of the probes was
108 to 109 cpm/µg DNA.
RNA Extraction and Analysis--
Methods described previously
were used for RNA analysis (25). Tissue culture cells were placed into
4 M guanidine thiocyanate, 0.5% sarcosyl, 25 mM sodium citrate, pH 7.0. The samples were immediately
homogenized. The homogenate was then loaded onto a cushion of 5.7 M CsCl, 0.1 mM EDTA, pH 7.0, and spun at
125,000 × g for 16 h. After centrifugation, the
pellet was dissolved in 10 mM HEPES, 1 mM EDTA,
0.1% SDS, pH 7.5, and precipitated by the addition of 2.5 volumes of
ethanol and sodium acetate (0.3 M final concentration). The
precipitate was then dissolved in diethyl pyrocarbonate-treated water,
and samples were immediately frozen at
80 °C until required.
For Northern blots, samples of 25 µg of total RNA were dissolved in
denaturing solution (5 mM HEPES, 0.05% SDS, 8%
formaldehyde), heated at 65 °C for 5 min and analyzed on a 1%
agarose gel containing 6.6% formaldehyde, 0.02 M MOPS, pH
7.2, and 0.002 M sodium citrate. RNA was transferred onto
Gene-Screen Plus and hybridized with the appropriate DNA hybridization
probes in 1.5 mM EDTA, 7% SDS, 0.5 M
NaH2PO4, 0.5 M
Na2HPO4 pH 7.0, at 65 °C for 24 h.
Blots were washed in 0.1% SDS and 0.1× SSC (0.15 M NaCl
and 0.015 M sodium citrate).
For the ribonuclease protection assay, the DNA template was generated
by cloning the pUHD10-3-derived XhoI/EcoRI
450-bp fragment containing the tet promoter, into the
XhoI/EcoRI sites of pBluescript KS
.
The template plasmid was digested with XhoI and antisense
RNA was synthesized using the MaxiscriptTM kit (Ambion),
following the protocol provided by the manufacturer (Ambion). RNase
protection was performed using the RPA IITM kit (Ambion).
Nuclear Run-off Assays--
Nuclei were prepared from rat
hepatoma cells as described previously (17). Briefly, plates were
washed three times in phosphate-buffered saline and scraped into
phosphate-buffered saline. Pelleted cells (600 × g,
4 °C for 5 min) were lysed in 10 mM Tris/HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.5% Nonidet
P-40 and incubated for 7 min at 4 °C. Nuclei were isolated by
centrifugation at 600 × g, 4 °C for 5 min. The
pellet was resuspended in the same buffer and centrifuged again. Nuclei
were suspended in 50 mM Tris/HCl, pH 8.3, 5 mM
MgCl2, 0.1 mM EDTA, 40% glycerol, and aliquots
were stored at
80 °C. Nuclear run-off assays were performed by the following method. Frozen nuclei (2 × 107 nuclei, 200 µl) were added to 200 µl of 25% glycerol, 10 mM
MgCl2, 0.2 M KCl, 1.2 mM ATP, 0.6 mM GTP, 0.6 mM CTP. After the addition of 40 units/ml RNase inhibitor and 100 µCi of [
-32P]UTP,
this mixture was incubated at room temperature for 45 min and the
reaction was stopped by the addition of RNase-free DNase I and 1/10
volume of 10 mM CaCl2. This mixture was
incubated at 37 °C for 30 min, after which 40 µl of 10× SET
buffer (5% SDS, 50 mM EDTA, 100 mM Tris/HCl,
pH 7.0), 20 µl of 2 mg/ml proteinase K, and 10 µl of 10 µg/ml
yeast tRNA was added. The reactions were then incubated at 37 °C for
30 min, extracted with 1 ml of RNAzol B mixed with 10% (v/v)
chloroform, and then precipitated with isopropanol at
20 °C.
Finally, the purified and washed RNA was dissolved in 100 µl of 0.5%
SDS. The radiolabeled RNA from each sample was denatured and hybridized
to dot blots containing 2 µg of purified cDNA fragments or total
rat genomic DNA immobilized onto nitrocellulose filters. Blots were
hybridized for 72 h at 45 °C in 1 ml of 1% bovine serum
albumin, 0.5 M sodium phosphate, and 7% SDS. The blots
were washed with 1× SSC, 0.1% SDS at 45 °C for 1 h and
exposed to film. Slots containing genomic DNA were used to normalize
the efficiency of the nuclear run-off reactions.
Evaluation of Transcriptional Activity and Quantitation of cat-1
mRNA Levels by Densitometric Analysis--
Signals on Northern
blots and nuclear run off experiments were quantified by using either a
PhosphorImager (Molecular Dynamics) or the densitometer CS SCAN 5000 (U. S. Biochemical Corp.). The efficiency of transcription of the
nuclei in amino acid-fed and amino acid-depleted cells was normalized
against the signal of total rat genomic DNA. Given that transcription
of many genes may be regulated in hepatoma cells, the choice of genomic
DNA was more reliable than a particular cellular gene and gave us reproducible data. The relative transcription rate was expressed as the
ratio of the individual cDNA autoradiographic signals over the
signal of total rat genomic DNA. Different autoradiographic exposure
times were used for quantitation, to ensure that the exposures were
within the linear range of the x-ray film and the detection instrument.
Amino Acid Transport Assays--
C6 and NRK cells were plated in
Costar 24-well plates at a density of 0.2-0.25 × 106
cells/well and cultured for 48 h (29).
trans-Stimulation experiments were performed by incubating
the cells for 1 h before the assay in dFBS-supplemented DMEM/F-12
or KRB, containing 2 mM lysine. For the transport study,
the cells were depleted for 5 min in choline KRP (119 mM
choline chloride, 5.9 mM KCl, 1.2 mM
MgSO4, 1.2 mM KHCO3, 5.6 mM glucose, 0.5 mM CaCl2, 25 mM choline HCO3) at 37 °C. Transport was
measured by incubating the cells in choline KRP containing
[3H]arginine (10 µCi/ml, 50 µM) and 2.5 mM leucine for 30 s at 37 °C. The cells were then
washed three times with ice-cold choline KRP, allowed to air-dry, and
dissolved in 0.2% SDS, 0.2 M NaOH. Aliquots were used for
scintillation counting and subjected to protein analysis using the
Lowry method. Values were corrected for nonspecific uptake, which was
measured in the presence of 2.5 mM unlabeled arginine.
y+ transport activity was calculated as pmol of Arg/mg of
protein/30 s.
Immunoblotting--
Cells were plated a day prior to subjecting
them to experimental condition. Cells were lysed after washing twice
with phosphate-buffered saline, in 50 mM Tris, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 2 mM EDTA, 10 mM NaF, 1 mM sodium
phosphate, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml
leupeptin, and 10 µg/ml aprotinin. Cell lysates were stored in
aliquots in
70 °C, after removing cellular debris by
centrifugation at 1000 × g for 10 min. A membrane
fraction was obtained by homogenizing cells in 20 mM
Tris/HCl, pH 7.4, 1 mM EDTA, 255 mM sucrose, 10 µg/ml leupeptin, and 10 µg/ml aprotinin in an all-glass homogenizer for 45 strokes. The homogenate was centrifuged at 16,000 × g for 15 min. The resulting supernatant was centrifuged at
200,000 × g for 1 h. The membrane pellet was
suspended in the same buffer, aliquoted, and stored at
70 °C. The
protein concentration of the samples was assayed by the Bio-Rad DC
protein reagent kit. Equal amounts of protein (20 µg) were prepared
in sample buffer (2% SDS, 0.02% bromphenol blue, 20% glycerol, 0.125 M Tris/HCl, pH 6.8, 1% mercaptoethanol) and analyzed on a
10% SDS-polyacrylamide gel. The gel was transferred onto Immobilon-P
membrane at 65 mA for 2 h at 20 °C using the Bio-Rad Transblot
apparatus. After transfer, the membranes were blocked overnight in
TBS-T (0.1% Tween 20, 20 mM Tris-buffered saline, pH 7.6)
containing 5% nonfat dried milk at 4 °C. Membranes were incubated
with the primary antibodies for 2 h at 25 °C and then washed
three times in TBS-T for 5 min each. Membranes were then incubated for
1 h with the appropriate secondary antibodies conjugated with
horseradish peroxidase in TBS-T containing 5% non fat dried milk.
Membranes were washed three times for 5 min each in TBS-T. Cat-1 and AS
were detected by the Enhanced Chemiluminescence (ECL) detection system
(Amersham Pharmacia Biotech). The membranes were exposed to Kodak XAR
film. The primary antibodies used were WCAT-1 anti-cat-1
antiserum and 3G6, a monoclonal antibody against human AS (30).
 |
RESULTS |
Amino Acid Depletion Induces cat-1 mRNA Levels in C6 Glioma and
NRK Kidney Cells--
cat-1 gene expression results in
accumulation of a major mRNA species of 7.9 kb and a minor one of
3.4 kb (25). The two mRNAs result from alternative polyadenylation
at two sites within the 3'-UTR (25). We have previously shown that the
levels of both mRNAs are increased when Fao hepatoma cells are
depleted of amino acids (17). To determine whether this regulation is a
general phenomenon, the effect of amino acid depletion on the accumulation of the cat-1 mRNAs in C6 glioma and NRK
kidney cell lines was studied. The cat-1 gene is expressed
in both cell lines grown in amino acid-containing medium, as evident
from the presence of the 7.9- and 3.4-kb mRNAs (Fig.
2, A and C). In
both cell lines, amino acid depletion caused an induction of both
cat-1 mRNA species. In NRK cells, the level of the
7.9-kb mRNA increased 3.8-fold in 2 h, reached a peak
(6.5-fold) in 6 h, and declined after 24 h (Fig. 2,
A and B). In C6 cells, the 7.9-kb
cat-1 mRNA levels peaked at 6 h (18-fold) and
remained elevated throughout the 36-h duration of the experiment (Fig.
2, C and D). A smaller increase in the level of
the 3.4-kb mRNA was observed (Fig. 2, A and
C). The increase was 2-fold for C6 and 3-fold for NRK cells.
As a positive control for regulation of gene expression by amino acid depletion, we measured the levels of AS mRNA (14), which is known
to be induced by amino acid depletion (10, 14). As expected, the AS
mRNA was increased similarly to the cat-1 mRNA (Fig.
2C). The levels of the mRNA for GAPDH and 18 S ribosomal
RNA were also measured. As expected (17), the level of the GAPDH
mRNA decreased after 24 and 36 h of amino acid starvation
(Fig. 2, A and C) and the level of the 18 S
ribosomal RNA did not change (Fig. 2C).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of amino acid depletion on the
concentration of the cat-1 mRNAs in C6 and NRK
cells. A and C, NRK and C6 cells,
respectively, were maintained in DMEM/F-12 medium supplemented with
10% FBS until they were 70% confluent (first lane). Medium was changed to KRB (S) or DMEM/F-12
(F) supplemented with 10% dFBS. At the indicated times, RNA
was isolated and Northern blot analysis was performed using probes for
cat-1, AS, GAPDH, and 18 S ribosomal RNA. B and
D, relative amounts of cat-1/7.9 mRNA were
determined in NRK and C6 cells from the autoradiograms in A
and C. The level in amino acid-fed cells was arbitrarily set
to 1.
|
|
The induction of the cat-1 mRNA could be due either to
increased mRNA stability or to increased transcription of the
cat-1 gene. We have therefore measured the effect of amino
acid depletion on the transcription rate of the cat-1 gene
using nuclear run-off. The transcription rate of the cat-1
gene remained the same during the 6 h of amino acid depletion in
both C6 (Fig. 3A) and NRK
cells (data not shown). These data are in agreement with our previous finding that induction of the cat-1 mRNA in amino
acid-depleted Fao cells is due to a post-transcriptional mechanism of
regulation (17). The transcription rates of two other genes known to be regulated by amino acid availability, AS (14) and jun (31), were also measured in this experiment. The transcription rate of
jun did not change, and the AS gene transcript was
undetectable (Fig. 3A).

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of actinomycin D and cycloheximide on
cat-1 mRNA levels during amino acid
depletion. A, nuclear run-off analysis of nuclei
isolated from C6 cells maintained in either DMEM/F-12 medium
supplemented with 10% dFBS (F) or KRB supplemented with
10% dFBS (S) for 4 h. 32P-Labeled RNA was
synthesized by isolated nuclei and hybridized against slot blots
containing cDNA fragments (GAPDH, AS, cat-1, JUN), rat
genomic DNA (gen), or Bluescript plasmid (pBS).
Slots containing rat genomic DNA were used to normalize the efficiency
of the nuclear run off reactions. Slots containing Bluescript plasmid
were used to determine background hybridization. B, Northern
blot analysis of RNA isolated from C6 and NRK cells maintained under
fed or amino acid-depleted conditions for 4 h in the presence or
absence of 10 µg/ml ActD or 10 µg/ml Cx. Analysis was performed
using cat-1, GAPDH, and c-fos probes.
|
|
Because the transcription rate of the cat-1 gene was not
altered by amino acid depletion, we tested whether transcription and
protein synthesis are required for mRNA induction. Although protein
synthesis is substantially reduced in amino acid-depleted cells, a
subset of mRNAs are able to be translated (1). C6 and NRK cells
were treated with either ActD or Cx during incubation in amino
acid-free medium. Both treatments completely abolished induction of
cat-1 mRNA in both cell lines (Fig. 3B). The
efficacy of Cx treatment was confirmed by demonstrating an increase in the level of c-fos mRNA (Fig. 3B), which is
induced by this compound (32). We conclude that both transcription and
protein synthesis are required for induction of cat-1
mRNA during amino acid depletion. As previously shown (Fig.
3A), the transcription rate of the cat-1 gene did
not change in amino acid-depleted cells when compared with fed cells.
The fact that ActD inhibits cat-1 mRNA induction in
amino acid-depleted cells suggests that transcription of the cat-1 gene is sustained during amino acid depletion. The
half-life of the cat-1/7.9-kb mRNA in amino acid-fed Fao
hepatoma cells has been previously estimated to be 90 min (25). As
expected, the level of the cat-1/7.9-kb mRNA in C6 cells
treated with ActD for 4 h is lower than the level in amino
acid-fed cells (Fig. 3B, compare first and
fourth lanes). Because this regulation is not at
the level of transcription, this finding suggests that a regulated
factor is involved in stabilizing the cat-1 mRNA in amino acid-depleted cells. This is further supported by the data showing that induction of the cat-1 mRNA in amino
acid-depleted cells is sensitive to protein synthesis inhibitors.
Treatment of cells with Cx during the 4 h of amino acid depletion
results in a cat-1/7.9-kb mRNA level similar to amino
acid-fed cells (Fig. 3B, compare first and
fifth lanes).
The cat-1 mRNA Is Stabilized in Amino Acid-depleted Cells by
Sequences in the 3'-UTR--
Our data suggest that amino acid
depletion increases cat-1 gene expression by stabilizing the
mRNA. To test this hypothesis, we studied the levels of a chimeric
tetcat-1 mRNA expressed from a regulated promoter. The
tetcat-1 gene was made by linking the cat-1
cDNA to a tetracycline-inducible promoter. The tetcat-1 cDNA contained 80 bp of vector sequence beginning at the
transcription start site followed by 80 bp of the 5'-UTR (Fig. 1), the
entire coding region, and entire 3'-UTR of the cat-1
cDNA (25). Expression of the tetcat-1 cDNA in cells
will result in accumulation of two mRNAs, of approximately 7.9 and
3.4 kb. These mRNAs result from the use of alternative
polyadenylation signals within the cat-1 cDNA. Both
tetcat-1 mRNAs contain 80 bp of tet vector
sequence at the 5'-UTR. C6 cells were transfected with the
tetcat-1 plasmid, along with a plasmid that expresses the
tetracycline-regulated transcriptional activator, rtTA (a fusion
between the Tet repressor and the activating domain of the
vp16 protein). Two stably transfected tet-responsive cell
lines (C6/7-3 and C6/7-5) were chosen for further studies. The cell
lines gave identical data; results from C6/7-3 are described below.
We first determined the effect of amino acid starvation on the level of
the chimeric tetcat-1 mRNA in C6/7-3 cells. Cells were
treated with the tetracycline analog, Dox, for 36 h or were kept
in Dox-free medium. Following Dox treatment the medium was changed to
either amino acid-containing or deficient medium in the presence of
Dox. RNA was isolated at 1-8 h of incubation and analyzed on Northern
blots, using the tet DNA probe, which is specific for the
chimeric tetcat-1 mRNA (Fig.
4, top). This probe hybridizes
with both the 7.9- and 3.4-kb tetcat-1 mRNAs. The
concentration of both tetcat-1 mRNAs increased following
treatment of amino acid-fed cells with Dox (Fig. 4, compare
first and second lanes), indicating
that expression of the chimeric construct showed the expected
regulation by Dox. When Dox-treated cells were shifted to amino
acid-depleted medium, there was a further time-dependent increase in the level of the 7.9-kb tetcat-1 mRNA.
Beginning at 2 h of depletion, the level of this mRNA
increased 5-fold over Dox-treated cells in amino acid-containing medium
and remained elevated throughout the 8-h course of the experiment. The
level of the 7.9-kb tetcat-1 mRNA showed a transient
small increase when Dox-treated cells were fed with fresh amino
acid-containing medium (Fig. 4, last three
lanes). This transient increase was probably due to the
change of medium, an effect that has been observed for other mRNAs
(33). The 5-fold increase of the tetcat-1 mRNA in amino
acid-depleted cells has been calculated over the transient 2-fold
increase of this mRNA in amino acid-fed cells. In contrast to the
induction of the 7.9-kb tetcat-1 mRNA in amino acid-depleted cells, the 3.4-kb tetcat-1 mRNA was not
changed by amino acid depletion of Dox-treated cells (Fig. 4, compare lanes 2 and 9). The same blot was
hybridized with a probe specific for the endogenous cat-1
gene. This probe was directed against a region of the cat-1
5'-UTR that was not contained in the tetcat-1 cDNA (Fig.
1). As shown in Fig. 4, the endogenous cat-1 mRNA was not affected by Dox treatment, but was induced 10-fold by amino acid
depletion, following the same time course as the 7.9-kb
tetcat-1 mRNA. Because the transcription rate of the
tet/cat-1 construct is not affected by amino acid
depletion, we conclude that the increase in mRNA level is caused by
stabilization of the message. Moreover, because the 3.4-kb
tetcat-1 mRNA was not induced by amino acid depletion,
we conclude that the 3'-UTR region that is present in the 7.9-kb but
not in the 3.4-kb mRNA (2860-6433, Fig. 1) contains cis
mRNA sequences involved in the stabilization of the
cat-1 mRNA in amino acid-depleted cells.

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 4.
C6/7-3 cells express a chimeric
tetcat-1 mRNA that is regulated by amino acid
depletion. Cells were maintained in FBS-supplemented DMEM/F-12 in
the presence of 0.1% G418. Medium was changed to FBS-supplemented
DMEM/F-12 (Fed) in the absence (lane 1) or presence (lanes 2-12) of Dox
for 36 h. Samples 1 and 2 were then harvested for analysis. The
medium in the remaining samples was then changed to dFBS-supplemented
KRB with Dox (Starved, lanes 3-9), or
dFBS-supplemented DMEM/F-12 with Dox (Fed, lanes 10-12) and the cells were cultured for the indicated times.
RNA was isolated and analyzed by Northern blotting using the probes
tet (top), 5'-cat-1
(middle), and GAPDH (bottom).
|
|
As a further test of the hypothesis that the tetcat-1
mRNA is stabilized by amino acid depletion, we looked at the effect of amino acid depletion on the level of tetcat-1 mRNA
after removal of Dox (Fig. 5,
A-E). In this experiment, C6/7-3 cells were treated with
Dox for 36 h in amino acid-containing media. The cells were then
shifted to Dox-free medium for 4 h, either in the presence or
absence of amino acids (Fig. 5A). It was expected that
transcription of the chimeric tetcat-1 gene would cease when
cells were shifted to Dox-free medium, leading to a decrease in the
tetcat-1 mRNA level. Our hypothesis was that if amino
acid depletion stabilizes the tetcat-1 mRNA, the
decrease in the chimeric message would be faster in amino acid-fed than
in amino acid-starved cells. The data in Fig. 5 (B and
C) support our hypothesis. Whereas the elevated
tetcat-1/7.9 mRNA level seen in Dox-treated cells (Fig. 5B, lane 2, bottom)
returned to base line when cells were shifted to Dox-free medium in
amino acid-containing medium (Fig. 5B, lane 3, bottom), the level remained elevated when
cells were shifted to Dox-free medium without amino acids (Fig.
5B, lane 4, bottom). This
conclusion was verified by performing an RNase protection assay
specific for the tetcat-1 RNA on the samples shown in Fig. 5B (Fig. 5D). Surprisingly, the concentration of
the tetcat-1 mRNA was higher in amino acid-depleted
cells shifted to Dox-free medium than in Dox-treated fed cells (Fig. 5,
B and C). This could be due to the fact that
removal of Dox from the medium does not turn off transcription of the
tetcat-1 gene immediately. As transcription continues in
amino acid-free medium, the tet/cat-1 mRNA is
stabilized, resulting in an increase in the mRNA level (Fig.
5C). A lag for cessation of transcription following removal
of Dox is better shown in Fig. 6
(A and B). C6/7-3 amino acid-fed cells maintained in Dox-containing media for 36 h were shifted to Dox-free media for 8 h. The tetcat-1 mRNA decayed with a half-life
of ~3.5 h, with a 2-h lag before the message level began to decrease
(Fig. 6B). However, an accurate evaluation of the mRNA
half-life could not be made using this method because the lag time
varied between experiments. Fig. 5B also shows that the
concentration of the endogenous cat-1 mRNA is not
affected by the treatment of cells with Dox and it is induced during
the 4 h of culture in amino acid-deficient medium (Fig.
5B, cat-1/7.9). It is noticeable that the
cat-1/7.9 mRNA was induced 4-fold in Fig. 5B, whereas
the induction obtained in the experiments described earlier was 10-fold (Fig. 4A). We should mention that we have experienced a
variation in the level of cat-1 mRNA induction between
experiments, possibly due to the quality of the dialyzed FBS.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
Increased stability of the cat-1 mRNA in amino acid-depleted cells involves
cis-acting mRNA sequences within the 3'-UTR.
A, experimental design. C6/7-3 and C6/R-5 cells were
maintained in FBS-supplemented DMEM/F-12 in the presence of 0.1% G418.
Medium was changed to FBS-supplemented DMEM/F-12 in the absence
(sample 1) or presence (sample 2) of Dox for 36 h. This was followed by culture in
dFBS-supplemented DMEM/F-12 in the absence of Dox (sample 3) or KRB (sample 4) in the absence of
Dox. B, Northern blot analysis of RNA using the
5'-cat-1, GAPDH, and tet probes. C,
levels of the tetcat-1/7.9-kb mRNA from B,
expressed as the ratio of cat-1/GAPDH mRNA.
D, RNase protection analysis of the RNA samples analyzed by
Northern blotting in B. The 32P-labeled RNA
probe (see "Experimental Procedures") hybridized with an 80-bp RNA
fragment representing the RNA transcript initiating within the
tet promoter (23). E, Northern blot analysis of
RNA isolated from C6/R-5 cells treated as described in A
(samples 1-4). Cat-1, GAPDH, and tet
probes were used for the analysis.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of Dox withdrawal on
tetcat-1 mRNA level in amino acid-fed C6/7-3
cells. A, C6/7-3 cells were maintained in
FBS-supplemented DMEM/F-12 (lane 1). Medium was
changed to FBS-supplemented DMEM/F-12 containing Dox for 36 h
(lane 2), followed by culture in medium without
Dox for the times indicated (lanes 3-6).
Northern blot analysis of RNA from these cells was performed using the
tet and GAPDH probes. B, levels of the
tetcat-1/7.9-kb mRNA level expressed as the ratio of
cat-1/GAPDH mRNAs, calculated from the autoradiogram in
A.
|
|
In order to further support our conclusion that degradation of the
cat-1 mRNA is slowed in amino acid-depleted cells, the half-life of the cat-1 mRNA was evaluated in either
amino acid-fed or amino acid-depleted C6 cells treated with ActD. Cat-1
mRNA levels were assessed in cells treated with ActD for less than 4 h because it is well known that accurate evaluation of mRNA half-life cannot be obtained from cells treated with ActD longer periods. As shown in Fig. 7 (A
and C), cat-1 mRNA decayed with a half-life
of approximately 120 min in amino acid-fed cells. In order to determine
the cat-1 mRNA half-life in amino acid-depleted cells,
cells were depleted of amino acids for 4 h and then treated with
ActD for an additional 4 h in the same medium. As shown in Fig. 7
(B and C), the level of cat-1 mRNA
did not change in depleted cells during the 4 h of ActD treatment,
suggesting an mRNA half-life much longer than 4 h. In order to
demonstrate that the cells remained healthy during the experiment, the
cat-1 mRNA level was assessed in cells incubated in
amino acid-deficient medium without ActD for 8 h. As expected, the
level of cat-1 mRNA in these cells was similar (1.5-fold
higher) to that found in cells depleted for 4 h (Fig.
7B, compare lanes 1 and 6).
In order to demonstrate the efficacy of ActD, the half-life of
c-myc mRNA was measured (Fig. 7, A and
B). As expected, the half-life of this mRNA was approximately 30 min in both amino acid-depleted and -fed cells (Fig.
7D). The experiments in Figs. 6 and 7 demonstrate a striking difference between the half-life of cat-1 mRNA in amino
acid-fed and -depleted cells using two different methods. In amino
acid-fed cells the half-life is approximately 120 min, whereas the
half-life in depleted cells is much longer. We conclude that
degradation of cat-1 mRNA is slowed by amino acid
depletion.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of amino acid depletion on the
half-life of the cat-1/7.9-kb mRNA in C6
cells. A, Northern blot analysis of RNA isolated from
C6 cells maintained in dFBS-supplemented DMEM/F-12 and incubated
with ActD for 0-150 min. Northern blot analysis was performed using
the cat-1/6.5, c-myc, and GAPDH hybridization
probes. B, Northern blot analysis of RNA isolated from C6
cells, which were depleted of amino acids for 4 h (lane 1) and then treated with ActD for an additional 4 h in
the same medium (lanes 2-5). The
cat-1 mRNA level was also assessed in cells incubated in
amino acid-deficient medium without ActD for 8 h (lane 6). Northern blot analysis was performed using the
cat-1/6.5, c-myc, and 18 S hybridization probes.
C and D, quantitation of the cat-1
(C) and c-myc (D) mRNA levels from
amino acid-fed (closed symbols) and amino
acid-depleted cells (open symbols) from the
Northern blots in A and B.
|
|
The data described above support the hypothesis that
trans-acting factors in amino acid-depleted cells interact
with sequences within the 3'-UTR and not within the coding region of
the cat-1 mRNA, resulting in increased stability. This
conclusion is drawn from the data showing that the 3.4-kb
tetcat-1 mRNA is not stabilized in amino acid-depleted
cells (Fig. 4A). The 3.4-kb tetcat-1 mRNA contains the entire coding region and 980 bp of 3'-UTR. To further support this finding, we analyzed the expression of a chimeric tetcat-1 gene (tetR5) that contained the
tet promoter linked to 1.1 kb of the 5'-end of the coding
region of the cat-1 cDNA (Fig. 1). When the experiment
described in Fig. 5A was carried out on cells expressing
tetR5, there was no difference in the level of the
tetR5 mRNA between amino acid-fed and -depleted cells
(Fig. 5E, compare last two
lanes), confirming the importance of the distal end of the
message in the stabilization of cat-1 mRNA in amino
acid-depleted cells.
Cat-1 Protein Synthesis Is Sustained in Amino Acid-depleted
Cells--
To test whether the observed increases in cat-1
mRNA result in accumulation of the protein in amino acid-depleted
cells, Cat-1 protein levels were examined. Studies on the Cat-1 protein
have been hampered by the difficulties investigators met in generating anti-cat-1 antibodies. These studies use an antibody,
Wcat-1, prepared against a C-terminal peptide. To test the specificity of this antibody, Western blot analysis was performed on cell extracts
from the mouse fibroblast cell line KO47, which contains a homozygous
knockout of the cat-1 gene (34), in parallel with extracts
from C6 cells. As expected, a set of protein bands at 80 kDa were seen
in C6 cells but not in the knockout cell line (Fig.
8A), probably representing
different degrees of glycosylation of the Cat-1 protein as has been
shown for other transporters (35). The specificity of the antibody was
demonstrated by performing Western blots in the presence of the
antigenic peptide, which blocked the appearance of the 80-kDa protein
bands (Fig. 8D).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 8.
Regulation of the level of the Cat-1 protein
in C6 cells by amino acid depletion. A, C6 and KO47
cells were maintained in DMEM/F-12 medium supplemented with 10% FBS
until they were 70% confluent. Whole cell lysates (20 µg of protein
each) were prepared and analyzed by immunoblotting using the WCAT-1
antibody. B and C, C6 cells were maintained in
DMEM/F-12 medium supplemented with 10% FBS until they were 70%
confluent (F). Medium was changed to dFBS-supplemented KRB
(S), and samples were collected at the indicated times and
analyzed by Western blotting as described under "Experimental
Procedures." A cell membrane fraction was used for Cat-1 protein
analysis (B). Whole cell lysates were used to analyze AS
protein (C). D, Western blot analysis of whole
cell lysates from C6 cells incubated in dFBS-supplemented KRB and
analyzed by immunoblotting using the WCAT-1 antibody ( ) or the WCAT-1
antibody in the presence of 0.1 µg/ml antigenic peptide (+).
|
|
Western blot analysis was used to determine whether the increased
cat-1 mRNA in amino acid-depleted cells leads to new
Cat-1 protein synthesis. Because protein synthesis is significantly decreased in depleted cells, an increase in Cat-1 protein will indicate
that the cat-1 mRNA is translated under conditions where the amino acid supply is derived from the breakdown of cellular proteins (36). In Fig. 8B it is demonstrated that
membrane-associated Cat-1 protein increased by 2-fold after 3 h of
amino acid depletion, and remained elevated for the 36-h duration of
the experiment. In a parallel experiment with the one presented in Fig.
8B, the level of the cat-1 mRNA was assessed
in C6 cells depleted of amino acids (Fig. 2, C and
D). Comparison of induction of the C6 cat-1 mRNA (18-fold, Fig. 2D) and protein (2-fold, Fig.
8B) levels suggests that the cat-1 mRNA is
not efficiently translated in amino acid-depleted cells when compared
with amino acid-fed cells. However, the cat-1 mRNA may
be translated more efficiently than other mRNAs in amino acid-depleted cells, because translation is significantly reduced under
these conditions (1). The 2-fold increase in the Cat-1 protein level
was observed in four independent experiments. The level of the
cat-1 mRNA was induced 15-18-fold in 6 h in all
four experiments (data not shown). To compare the behavior of the Cat-1 protein with a protein known to be regulated by amino acid starvation, a Western blot of total cell extracts from the same experiment described in Fig. 8B was immunoblotted with an antibody
against AS (Fig. 8C). As expected (14), AS was induced in
amino acid-depleted cells following the same time course as AS mRNA
(Fig. 2C). This behavior is similar to that observed with
Cat-1 protein, with the difference that the AS protein and mRNA are
induced to similar extents. Therefore, we conclude that the induced
cat-1 mRNA, like the AS mRNA, is translated in cells
where the principal source of amino acids is protein catabolism.
System y+ Arginine Transport Is Induced in Amino
Acid-depleted Cells--
To determine whether the changes in
cat-1 mRNA and protein induced by amino acid depletion
are reflected in a change in transport activity, we evaluated the
uptake of L-[3H]arginine by C6 and NRK cells.
Because system y+ amino acid transporters carry out the
exchange of amino acids, transport is slowed in amino acid-depleted
cells. This inhibition probably results from a lack of amino acids in
the cytosol, preventing exchange across the plasma membrane.
Consequently, to compare the transport activity in amino acid-fed and
-depleted cells, cells were incubated in the appropriate medium
containing 2 mM lysine for 1 h prior to assay, because
this amino acid is a substrate for y+ transport systems. In
fact, in amino acid-depleted C6 and NRK cells, this incubation with
lysine stimulated the uptake of
L-[3H]arginine by 3.5- and 5.5-fold
(trans-stimulation), respectively, in agreement with
previous results (data not shown; Ref. 17). Because this
trans-stimulation allows us to measure transport at maximal
rates, these conditions were used to compare the level of functional
y+ transporters in amino acid-fed and -depleted cells.
Measurement of arginine uptake in both NRK and C6 cells revealed that
amino acid depletion resulted in a stimulation of transport activity
(Fig. 9). In both cell lines, amino acid
depletion caused a 75% increase in transport over the activity seen in
amino acid-fed cells (Fig. 9). These results demonstrate that the
increased cat-1 mRNA in amino acid-depleted cells is
translated into functional transporters in the plasma membrane that
participate in the uptake of cationic amino acids.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 9.
[3H]Arginine uptake into amino
acid-depleted cells. C6 and NRK cells were maintained in
FBS-supplemented DMEM/F-12. The medium was changed to dFBS-supplemented
DMEM/F-12 (Fed) or KRB (Starved) for 5 h,
followed by 1 h of incubation in the corresponding medium in the
presence of 2 mM lysine. y+ transport activity
was measured as described under "Experimental Procedures." Values
are mean ± standard deviation of four independent
experiments.
|
|
 |
DISCUSSION |
The sequence of molecular events leading to increased arginine
transport in amino acid-deprived cells was studied here. Amino acid
deprivation induced cat-1 mRNA levels by 4-18-fold in
the cell lines studied (Fig. 1). The data clearly establish that this regulation occurs primarily at the post-transcriptional level, because
the effect of amino acid depletion on the transcription rate is
minimal. We therefore suggest that amino acid depletion increases
cat-1 mRNA stability. The post-transcriptional
regulation is not a general response to stress because heat shock had
no effect on cat-1 mRNA levels (data not shown).
cis-Acting sequences of mRNAs that increase stability in
response to biological and pharmacological stimuli, have mainly been found within the coding regions (37), or the 3'-UTRs (38). Our studies
of a chimeric tetcat-1 gene in C6 cells suggest that sequences within the 3'-UTR of the cat-1 mRNA are
involved in this stabilization. Two tetcat-1 chimeric
mRNAs, at 7.9 and 3.4 kb, were expressed from the
tetcat-1 cDNA. These mRNAs result from the use of
alternative polyadenylation signals (Fig. 1). Expression of the
tetcat-1/3.4-kb mRNA was not affected by amino acid
depletion, whereas depletion caused a 5-fold increase in the
tetcat-1/7.9-kb. This demonstrates that only the larger
mRNA contains sequences necessary for stabilization. Therefore, we suggest that the cis mRNA sequences involved in
increased mRNA stability are found in the 3'-UTR sequence of the
7.9-kb mRNA, which is not present in the 3.4-kb mRNA (25). The
precise cis mRNA sequences and trans-acting
factors that are involved in stabilizing the cat-1 mRNA
are not known. Our hypothesis is that, in amino acid-depleted cells,
either the degradation of the cat-1 mRNA is inactivated
or a protein factor is synthesized that stabilizes the mRNA.
Because the half-life of the cat-1 mRNA in C6 amino
acid-fed cells is 120 min (25) and the 3'-UTR sequences contribute to this short half-life (25), it is possible that A/U-rich sequences (ARE)
within the 3'-UTR (25) are involved in its rapid turnover. It is well
known that AREs in the 3'-UTR of short-lived mRNAs facilitate their
destabilization (39, 40). The 3'-UTR of the cat-1 mRNA
contains three dispersed copies of the ARE sequence AUUUA and the
sequence (AU)11 (25). It has been suggested that the decay
of ARE-containing mRNAs is promoted by a family of ARE-binding proteins known as AUF1 (41). Recently, Schneider and co-workers (42)
demonstrated that the ubiquitin-proteasome pathway is involved in
regulating the degradation of these A/U-rich mRNAs. Rapid decay involves a complex of AUF1 with heat shock proteins, translation initiation factor eIF4G, and poly(A)-binding protein (42). Induction of
hsp70 by heat shock and inactivation of the ubiquitin-proteasome pathway result in sequestration of AUF1 by hsp70 and inhibition of
AU-rich mRNA decay (42). Sequestration of AUF1 could participate in
the inhibition of cat-1 mRNA turnover in amino
acid-depleted cells. However, inactivation of AUF1 cannot be the only
regulator of cat-1 mRNA turnover in amino acid-depleted
cells, because heat shock had no effect on cat-1 mRNA stability.
An alternative mechanism that could stabilize the cat-1
mRNA in amino acid-depleted cells is the synthesis of a protein
factor(s) that binds to the mRNA preventing its degradation. This
type of regulation has been described for regulation of mRNAs
encoding transferrin receptor (43) and other proteins (44).
Furthermore, it has been shown that a strong secondary structure 5' to
an ARE within the 3'-UTR of short-lived mRNAs blocks rapid
degradation of the corresponding mRNA (45). The 3'-UTR of the
7.9-kb but not the 3.4-kb cat-1 mRNA contains ARE
elements and a stable secondary structure upstream of the
(AU)11 sequence (data not shown). It is therefore possible
that a protein synthesized in amino acid-depleted cells stabilizes the
cat-1 mRNA by enforcing a stable secondary structure
upstream of the (AU)11 sequence. This sequence is presently under investigation for its involvement in the regulation of
cat-1 mRNA decay in amino acid-depleted cells.
Control of mRNA turnover has been linked to its ability to be
translated. Although the mechanism of mRNA turnover is not well understood, there is convincing evidence that activation of decay requires translation of the message (16). However, increased stability
of mRNAs caused by biological stimuli can be independent of
translation of the corresponding message (45). In our studies we have
shown that protein synthesis is required for cat-1 mRNA induction in amino acid-depleted cells. This suggests either that cat-1 mRNA stability in these cells is associated with
its ability to be translated or that translation is required for the
synthesis of a protein factor that stabilizes the mRNA. Our data
support the possibility that stabilization of the cat-1
mRNA in amino acid-depleted cells does not depend on its ability to
be translated. Because the increase in the level of the Cat-1 protein
(2-fold) was lower than the increase in the level of mRNA
(18-fold), we conclude that the cat-1 mRNA is
inefficiently translated in amino acid-depleted cells, relative to
amino acid-fed cells. Furthermore, induction of the Cat-1 protein was
similar in amino acid-depleted C6 cells and C6/7-3, cells which express
the tetcat-1 chimeric gene (data not shown). The latter
suggests that the tetcat-1 mRNA may not be translated in
amino acid-depleted cells. An inability of the tetcat-1
mRNA to be translated may be due to the absence of the entire
5'-UTR (Fig. 1). Therefore, it is likely that translation during amino
acid depletion is required for the synthesis of a regulatory protein
that increases cat-1 mRNA stability. This conclusion is
supported by the finding that treatment of amino acid-depleted cells
with a protein synthesis inhibitor leads to a decrease of cat-1 mRNA to fed levels (data not shown). Further
support is given by the finding that levels of both tetcat-1
and endogenous cat-1 mRNAs did not increase during the
first 2 h of amino acid depletion. The lag time of 2 h may be
required for the synthesis of the regulatory protein that increases
cat-1 mRNA stability. An alternative explanation is that
the 2 h lag is required to generate the signal that triggers
changes in gene expression in amino acid-depleted cells.
The question raised from the studies described in this paper is why
cat-1 mRNA level increases in amino acid-depleted cells if the mRNA is not going to be translated into more Cat-1 protein. As is well known (1), 5'-cap-dependent protein synthesis
decreases significantly in amino acid-depleted cells. Similar to the
majority of cellular mRNAs, cat-1 mRNA is
inefficiently translated in amino acid-depleted cells, relative to
amino acid-fed cells. This suggests that the increased cat-1
mRNA level compensates for the inefficient translation and sustains
the level of Cat-1 protein during the time of depletion. The fact that
Cat-1 protein accumulates for as long as 36 h in amino
acid-depleted cells indicates that it is either a stable protein or
that continuous synthesis occurs. An alternative explanation for the
induction of the Cat-1 protein in amino acid-depleted cells is that it
results from translation of the cat-1/3.4-kb mRNA,
whereas the cat-1/7.9-kb is not translated. If this is true,
the 2-fold induction of the protein would agree with the 2-3-fold
induction of the cat-1/3.4-kb mRNA. Future studies will
determine the efficiency of translation of the two cat-1 mRNAs in amino acid-depleted cells.
The level of y+ arginine transport in amino acid-depleted
cells is induced to the same extent as Cat-1 protein. We have
previously shown that system y+ arginine transport is
induced in trans-stimulated amino acid-depleted Fao hepatoma
cells (17). We have shown in this report that system y+
transport is also induced in amino acid-depleted NRK and C6 cells. We
conclude that induction of the cat-1 mRNA in amino
acid-depleted cells occurs to sustain Cat-1 protein level and cationic
amino acid transport both during depletion and once amino acids become available.
Levels of the mRNAs for cat-1 and AS show similar
regulation (10, 15). Regulation of the AS gene by amino acid depletion has been shown to occur at the transcriptional and post-transcriptional levels (10, 15). Although the transcription rate of the AS gene in
amino acid-fed and -starved cells could not be detected by nuclear
run-off (Fig. 2A), studies of chimeric genes indicated that
the AS promoter is subject to transcriptional regulation in amino
acid-depleted cells (15). It is therefore possible that
cat-1 gene transcription is regulated by amino acid
depletion, even though this was not detected by our methods.
In support of this possibility is the finding that a 2-3-fold increase
in the level of the cat-1/3.4-kb mRNA was observed in
amino acid-depleted cells (17).
The pathways by which amino acid depletion triggers changes in gene
expression in mammalian cells are not known. It has been suggested that
increased levels of uncharged tRNAs trigger the regulation of gene
expression by either increasing transcription or mRNA stability
(5). These events may involve the synthesis of new proteins or the
modification of existing proteins that may act as transcription factors
or mRNA stabilizing/binding proteins. In support of a signal
transduction pathway linked to modulation of gene expression is the
report that p70 s6 kinase is dephosphorylated in amino acid-depleted
cells leading to its deactivation, probably through a negative
regulation of its activity by a pathway involving suppression of tRNA
aminoacylation (46).
The molecular events that regulate gene expression in response to
changes in the nutrient supply have been extensively studied in
prokaryotes and lower eukaryotes (5). Mammalian cells also have
mechanisms to respond to nutrient availability (5). We have shown here
that part of this response involves the induction of cat-1
transporter gene expression by a mechanism that involves post-transcriptional stabilization of the mRNA. Future studies will
show if other transporter proteins are also induced in response to
amino acid starvation. Studies on the regulation of amino acid transporter genes by amino acid availability will increase our understanding of regulation of amino acid transport in animal and human
cells during periods of limited dietary protein supply.
 |
FOOTNOTES |
*
This work was supported by Grant RO1 DK53307-01 (to M. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Nutrition, Case Western Reserve University School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106. Tel.: 216-368-3012; Fax:
216-368-6644; E-mail: mxh8@po.cwru.edu.
2
M. Hatzoglou, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
AS, asparagine
synthase;
ActD, actinomycin D;
ARE, A/U-rich element;
bp, base pair(s);
kb, kilobase pair(s);
Cat-1, cationic amino acid transporter 1;
Cx, cycloheximide;
Dox, doxycycline;
GAPDH, glyceraldehyde-3-phosphate
dehydrogenase;
KRB, Krebs-Ringer bicarbonate buffer;
tet, tetracycline;
UTR, untranslated region;
FBS, fetal bovine serum;
dFBS, dialyzed fetal bovine serum;
DMEM, Dulbecco's modified Eagle's
medium;
TBS-T, Tris-buffered saline with Tween 20;
MOPS, 4-morpholinepropanesulfonic acid.
 |
REFERENCES |
| 1.
|
Pain, V. M.
(1994)
Biochimie
76,
718-728[Medline]
[Order article via Infotrieve]
|
| 2.
|
Marten, N. W.,
Burke, E. J.,
Hayden, J. M.,
and Straus, D. S.
(1994)
FASEB J.
8,
538-544[Abstract]
|
| 3.
|
Scorsone, K. A.,
Panniers, R.,
Rowlands, A. G.,
and Henshaw, E. C.
(1987)
J. Biol. Chem.
262,
14538-14543[Abstract/Free Full Text]
|
| 4.
|
Price, N.,
and Proud, C.
(1994)
Biochimie
76,
748-760[Medline]
[Order article via Infotrieve]
|
| 5.
|
Laine, R. O.,
Shay, N. F.,
and Kilberg, M. S.
(1994)
J. Biol. Chem.
269,
9693-9697[Abstract/Free Full Text]
|
| 6.
|
Merrick, W. C.,
and Hershey, J. W. B.
(1996)
in
Translational Control
(Hershey, J. W. B.
, Mathews, M. B.
, and Sonenberg, N., eds)
, pp. 31-70, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 7.
|
Weck, S. A.,
Zhu, S.,
and Weck, R. C.
(1995)
Mol. Cell. Biol.
15,
4497-4506[Abstract]
|
| 8.
|
Albrecht, G.,
Mosch, H.-U.,
Hoffman, B.,
Reusser, U.,
and Braus, G. H.
(1998)
J. Biol. Chem.
273,
12696-12702[Abstract/Free Full Text]
|
| 9.
|
Ogawa, H.,
Fujioka, M.,
Su, Y.,
Kanamoto, R.,
and Pitot, H. C.
(1991)
J. Biol. Chem.
266,
20412-20417[Abstract/Free Full Text]
|
| 10.
|
Gong, S. S.,
Guerrini, L.,
and Basilico, C.
(1991)
Mol. Cell. Biol.
11,
6059-6066[Abstract/Free Full Text]
|
| 11.
|
Chen, Z. P,
and Chen, K. Y.
(1992)
J. Biol. Chem.
267,
6946-6951[Abstract/Free Full Text]
|
| 12.
|
Ponjanpelto, P.,
and Holtta, E.
(1990)
Mol. Cell. Biol.
10,
5814-5821[Abstract/Free Full Text]
|
| 13.
|
Plakidou-Dymock, S.,
and McGivan, J. D.
(1993)
Biochem. J.
295,
749-755
|
| 14.
|
Hutson, R. G,
and Kilberg, M. S
(1994)
Biochem. J.
304,
745-750
|
| 15.
|
Guerrini, L.,
Gong, S. S.,
Mangasarian, K.,
and Basilico, C.
(1993)
Mol. Cell. Biol.
13,
3202-3212[Abstract/Free Full Text]
|
| 16.
|
Jacobson, A.,
and Peltz, S. W.
(1996)
Annu. Rev. Biochem.
65,
693-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Hyatt, S. L.,
Aulak, K. S.,
Malandro, M.,
Kilberg, M. S.,
and Hatzoglou, M.
(1997)
J. Biol. Chem.
272,
19951-19957[Abstract/Free Full Text]
|
| 18.
|
White, M. F.,
and Christensen, H. N.
(1982)
J. Biol. Chem.
257,
4450-4457[Abstract/Free Full Text]
|
| 19.
|
MacLeod, C.,
Finley, K. D.,
and Kakuda, D. K.
(1994)
J. Exp. Biol.
196,
109-121[Abstract/Free Full Text]
|
| 20.
|
Ito, K.,
and Groudine, M.
(1998)
J. Biol. Chem.
272,
26780-26786[Abstract/Free Full Text]
|
| 21.
|
Hosokawa, H.,
Sawamura, T.,
Kobayashi, S.,
Ninomiya, H.,
Miwa, S.,
and Masaki, T.
(1998)
J. Biol. Chem.
272,
8717-8722[Abstract/Free Full Text]
|
| 22.
|
Wu, J.-Y.,
Robinson, D.,
Kung, H. J.,
and Hatzoglou, M.
(1994)
J. Virol.
68,
1615-1623[Abstract/Free Full Text]
|
| 23.
|
Gossen, M.,
and Bujard, H
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5547-5551[Abstract/Free Full Text]
|
| 24.
|
Puppi, M.,
and Henning, S. J.
(1995)
Assoc. Soc. Exp. Biol. Med.
209,
38-45
|
| 25.
|
Aulak, K. S.,
Liu, J.,
Hyatt, S. L.,
Puppi, M.,
Henning, S. J.,
and Hatzoglou, M.
(1996)
J. Biol. Chem.
271,
29799-29806[Abstract/Free Full Text]
|
| 26.
|
Maniatis, T.,
Fritsch, E. F.,
and Sambrook, J.
(1982)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 27.
|
Land, H.,
Parada, L. F.,
and Weinberg, R. A
(1983)
Nature
304,
596-602[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Katz, R. A,
Erlanger, B. F.,
and Guntaka, R. V.
(1983)
Biochim. Biophys. Acta
739,
258-264[Medline]
[Order article via Infotrieve]
|
| 29.
|
Kilberg, M. S.,
Heping, H.,
Barber, E. F.,
and Chiles, T. C.
(1985)
J. Cell. Physiol.
122,
290-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Sheng, S.,
Moraga, D. A.,
van Heeke, G.,
and Shuster, S. M.
(1992)
Protein Exp. Purif.
3,
337-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Pohjanpelto, P.,
and Holta, E.
(1990)
Mol. Cell. Biol.
10,
5814-5821
|
| 32.
|
Morello, D.,
Lavenu, A.,
and Babinet, C.
(1990)
Oncogene
5,
1511-1519[Medline]
[Order article via Infotrieve]
|
| 33.
|
Kalousen, M. B.,
Trub, T.,
Schuermann, M.,
and Klemenz, R.
(1994)
J. Biol. Chem
269,
6866-6873 |